Clinical Trial Update: Expanded Access for BLZ-100 (Tozuleristide)

View source ↗

Summary

The expanded access program for BLZ-100 (tozuleristide) is no longer available. Blaze Bioscience previously sponsored this access for cancer imaging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• BLZ-100 (Tozuleristide) (tozuleristide)

Snippet

Sponsor: Blaze Bioscience Inc. | Status: NO_LONGER_AVAILABLE